Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 3, 2007, Pages 920-925

  Odoardi, Francesca ^a   Kawakami, Naoto ^a   Li, Zhaoxia ^a   Cordiglieri, Chiara ^a   Streyl, Kristina ^a   Nosov, Mikhail ^a   Klinkert, Wolfgang E F ^a   Ellwart, Joachim W ^b   Bauer, Jan ^c   Lassmann, Hans ^c   Wekerle, Hartmut ^a   Flügel, Alexander ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmunity; Live imaging

Indexed keywords

CD134 ANTIGEN; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; MYELIN BASIC PROTEIN;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL AGGREGATION; CELL MOTILITY; CONTROLLED STUDY; EFFECTOR CELL; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPLEEN; STROMA CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; KINETICS; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS; RATS; SOLUBILITY; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 33846533787     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0608383104     Document Type: Article

References (45)

1. Levine S, Hoenig EM, Kies MW (1968) Science 161:1155-1157.
2. Critchfield JM, Racke MK, Zũiga-Pflücker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ (1994) Science 263:1139-1143.
3. Flügel A, Willem M, Berkowicz T, Wekerle H (1999) Nat Med 5:843-847.
4. Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne D, Li Z, Ellwart J, Willem M, Lassmann H, Wekerle H (2001) Immunity 14:547-560.
5. Kawakami N, Nägerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flügel A (2005) J Exp Med 201:1805-1814.
6. Miller MJ, Wei SH, Cahalan MD, Parker I (2003) Proc Natl Acad Sci USA 100:2604-2609.
7. Miller MJ, Wei SH, Parker I, Cahalan MD (2002) Science 296:1869-1873.
8. Shimonkevitz R, Kappler JW, Marrack P, Grey H (1983) J Exp Med 158:303-316.
9. Mebius RE, Kraal G (2005) Nat Rev Immunol 5:606-616.
10. Miller MJ, Safrina O, Parker I, Cahalan MD (2004) J Exp Med 200:847-856.
11. Benvenuti F, Hugues S, Walmsley M, Ruf S, Fetler L, Popoff M, Tybulewicz VLJ, Amigorena S (2005) Science 305:1150-1153.
12. Revy P, Sospedra M, Barbour B, Trautmann A (2001) Nat Immunol 2:925-931.
13. Catron DM, Itano AA, Pape KA, Mueller DL, Jenkins MK (2004) Immunity 21:341-347.
14. Mempel TR, Henrickson SE, von Andrian UH (2004) Nature 427:154-159.
15. Nolte MA, Beliën JAM, Schadee-Eestermans IL, Jansen W, Unger WWJ, Van Rooijen N, Kraal G, Mebius RE (2003) J Exp Med 198:505-512.
16. Trombetta ES, Mellman I (2005) Annu Rev Immunol 23:975-1028.
17. Manickasingham S, Reis e Sousa C (2000) J Immunol 165:5027-5034.
18. Harding CV, Geuze HJ (1992) J Cell Biol 119:531-542.
19. Rodriguez GM, Diment S (1995) Eur J Immunol 35:1823-1827.
20. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, Pabst R, Lutz MB, Sorokin LM (2005) Immunity 22:19-29.
21. Zell T, Khoruts A, Ingulli E, Bonnevier JL, Mueller DL, Jenkins MK (2001) Proc Natl Acad Sci USA 98:10805-10810.
22. Donnadieu E, Cefal D, Tan YP, Paresys G, Bismuth G, Trautmann A (1992) J Immunol 148:2643-2653.
23. Faure S, Salazar-Fontana LI, Semichon M, Tybulewicz VLJ, Bismuth G, Trautmann A, Germain RN, Delon J (2004) Nat Immunol 5:272-279.
24. Negelescu PA, Krasieva TB, Khan A, Kerschbaum HH, Cahalan MD (1996) Immunity 4:421-430.
25. Weiss A, Shields R, Newton M, Manger B, Imboden J (1987) J Immunol 1138:2169-2176.
26. Hayashi N, Liu D, Min B, Ben-Sasson S, Paul WE (2002) Proc Natl Acad Sci USA 99:6187-6191.
27. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Trends Neurosci 9:271-277.
28. Hickey WF, Hsu BL, Kimura H (1991) J Neurosci Res 28:254-260.
29. Ransohoff RM, Kivisäkk P, Kidd G (2003) Nat Rev Immunol 3:569-581.
30. Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, et al. (2000) Nat Med 6:1167-1175.
31. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L (2000) Nat Med 1176-1182.
32. Pedotti R, Mitchell D, Wedemeyer J, Karpuj M, Chabas D, Hattab EM, Tsai M, Galli SJ, Steinman L (2001) Nat Med 2:216-222.
33. Campbell B, Vogel PJ, Fisher E (1973) Arch Neurol 29:10-15.
34. Gonsette RE, Delmotte P, Demonty L (1977) J Neurol 216:27-31.
35. Romine JS, Salk J (1983) in Multiple Sclerosis, eds Hallpike J, Adams CWM, Tourtellotte WW (Cambridge Univ Press, Cambridge, UK), pp. 621-630.
36. Tian J, Olcott A, Hanssen L, Zekzer D, Kaufman DL (1999) Immunol Today 20:190-194.
37. Vanderlugt CL, Miller SD (2002) Nat Rev Immunol 2:85-95.
38. Robinson WH, Fontoura P, Lee BJ, De Vegvar HEN, Tom J, Pedotti, R., DiGennaro CD, Mitchell DJ, Fong D, Ho PPK, et al. (2003) Nat Biotechnol 21:1033-1039.
39. McFarland HI, Lobito AA, Johnson MM, Palardy GR, Yee CSK, Jordan EK, Frank JA, Tresser N, Genain CP, Mueller JP, et al. (2001) J Immunol 166:2116-2121.
40. Zhong, M.-C., Kerlero de Rosbo N, Ben-Nun A (2002) J Clin Invest 110:81-90.
41. Hohlfeld R, Wekerle H (2004) Proc Natl Acad Sci USA 101(Suppl 2):14599-14606.
42. Eylar EH, Kniskern PJ, Jackson JJ (1979) Methods Enzymol 32B:323-341.
43. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J-M, Gardinier MV, Dornmair K, Linington C (1995) J Neuroimmunol 63:17-27.
44. Kawakami N, Odoardi F, Ziemssen T, Bradl M, Ritter T, Neuhaus O, Lassmann H, Wekerle H, Flügel A (2005) J Immunol 175:69-81.
45. Kawakami N, Lassmann S, Li Z, Odoardi F, Ritter T, Ziemssen T, Klinkert WEF, Ellwart J, Bradl M, Krivacic, K, et al. (2004) J Exp Med 199:185-197.